Related Experiment Video
Updated: Jan 19, 2026

08:29
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
10.5K
Context is everything: aneuploidy in cancer.
Uri Ben-David1, Angelika Amon2,3,4
1Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ubendavid@tauex.tau.ac.il.
Nature Reviews. Genetics
|September 25, 2019
Summary
Aneuploidy, or abnormal chromosome numbers, drives cancer development differently based on cancer type. This context-dependent event shows promise as a prognostic marker and therapeutic target.
Area of Science:
- Genetics
- Cancer Biology
- Genomic Instability
Background:
- Cancer arises from diverse genetic alterations, including point mutations and aneuploidy (whole-chromosome gains/losses).
- Chromosome instability, leading to aneuploidy, fuels tumor progression by increasing genetic diversity.
- The specific role of aneuploidy in tumor formation and progression remains less understood compared to its upstream cause.
Purpose of the Study:
- To investigate the context-dependent role of aneuploidy in tumorigenesis.
- To explore aneuploidy as a cancer-type-specific oncogenic event.
- To assess the clinical relevance of aneuploidy as a prognostic marker and therapeutic target.
Main Methods:
- Review of recent studies on aneuploidy in cancer.
- Analysis of cancer-type-specific genomic alterations.
- Evaluation of clinical data linking aneuploidy to patient outcomes.
Main Results:
- Aneuploidy is not a universal driver of cancer, unlike some oncogenes or tumor suppressors.
- The oncogenic contribution of aneuploidy varies significantly across different cancer types.
- Emerging evidence suggests aneuploidy's potential as a biomarker and therapeutic target.
Conclusions:
- Aneuploidy's role in cancer is context-dependent and cancer-type specific.
- Understanding these specific roles is crucial for developing targeted therapies.
- Aneuploidy represents a promising avenue for cancer prognosis and treatment.
Related Concept Videos
Nondisjunction
4.8K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.8K
Nondisjunction
81.8K
During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
81.8K
Cancers Originate from Somatic Mutations in a Single Cell
14.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Cancer
53.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.5K

